Early-stage research indicated that stem-cell islet therapy (VX-880) has shown potential to support insulin production (shown by C-peptide levels) in some people with type 1 diabetes. Learn more here: diabetes.org/newsroom/press… #stemcelltherapy #diabetes #biotech #konectar

Legacy tools can’t keep up with evolving KOL influence. With #konectar, #MedicalAffairs teams get dynamic #KOLtiering, AI-powered scoring, and a single source of truth. Learn more: aissel.com/blog/why-kol-t… or request a personalized demo bit.ly/43N3vh3 #KOLengagement

We’re curious what helps keep your project timelines on track. The most effective time-saver in your #KOLworkflow is ___? A) Automation tools B) Centralized analytics C) Clear processes D) Team collaboration Have a different answer? We’d love to hear it—comment below! #KOLs #HCPs

#FDA approves Harliku, the first treatment for #alkaptonuria (AKU). Cycle #Pharmaceuticals plans a U.S. launch this July, offering a breakthrough for ultra-rare disease care. biospace.com/fda/cycle-wins…

Did you know? Researchers are exploring new therapies for people with very high blood fats (#hyperlipoproteinemia)—a major heart risk. These treatments aim to change how the body processes fats to LDL cholesterol. pmc.ncbi.nlm.nih.gov/articles/PMC12… #ClinicalData #DrugDevelopment #FDA

The best KOL engagement strategy starts with trust, leads with science, and runs on real-time insights. Here is how MSLs are turning that into strategy. aissel.com/blog/msl-engag…

Praxis’ vormatrigine shows a 56.3% reduction in seizures in a Phase II trial—outperforming Xcopri and XEN-1101. 22% of patients saw complete seizure freedom, with no titration needed. A clean safety profile and daily dosing make this one to watch. biospace.com/drug-developme…

Conferences can make or break your Medical Affairs strategy. Here are 5 challenges MA teams face and how to win against each one aissel.com/blog/top-5-cha… #MedicalAffairs #KOLManagement #konectar

In a decentralized healthcare system, local KOLs play a key role in driving scientific influence. This blog explores why regional engagement matters—and how konectar empowers life sciences teams to make it happen. aissel.com/blog/find-kols…

Did you know? In a phase 3 trial, Candel's CAN-2409 reported reduced prostate cancer recurrence by 30%. After 2 years, the treatment induced pathological complete responses in 80% of the patients vs 64% of the control group. fiercebiotech.com/biotech/candel…

Around 15 million adults in the US live with MASH, a silent liver disease that can lead to cirrhosis or cancer. Now, the FDA has approved Wegovy as the first treatment option. This is a huge step towards addressing this public health issue. fda.gov/drugs/news-eve…

Conferences don't end with the closing sessions. With konectar post-conference analytics, teams can turn event data into strategic actions that boost engagement and streamline decision-making. Explore more here aissel.com/blog/post-conf… #medicalaffairs #kolmanagement #konectar

Conferences are more than networking opportunities — they can be a goldmine for insights that can shape engagement strategies. Why are post-conference insights valuable for pharma teams?

Innovation isn't impact until it's visible. That's what Scientific Share of Voice (SSoV) measures — your brand's presence in publications, citations, & scientific conversations. With konectar SSoV Analytics, you don't just track visibility, you lead it. aissel.com/blog/scientifi…

Major milestone in Huntington's Disease: uniQure's gene therapy AMT-130 slowed progression by 75% at 36 months in Phase I/II. This is a major step forward towards redefining the future for treatment of HD. Read more: uniqure.gcs-web.com/news-releases/…

Most CVD cases are preventable with early check-ups and healthy habits. This #WorldHeartDay, schedule your heart screening and commit to 25 minutes of movement a day. #DontMissABeat.

Scattered tools are slowing down medical affairs. konectar unifies KOL/DOL identification, network mapping, & a CRM — and delivers SSoV & Conference Analytics reports to get insights on what matters most.aissel.com/blog/why-konec…

Did you know? New research finds glioblastomas don't just damage the brain, they erode the skull, alter marrow, and disrupt immunity. This breakthrough may change how we fight the deadliest brain cancer biospace.com/press-releases…

Mental health care is every individual's right. This #WorldMentalHealthDay, we're raising awareness about the importance of accessible mental health services in case of emergencies. Because care shouldn't be the first thing lost during disasters. #MentalHealthMatters

Can your medical team see the full picture of every KOL relationship? konectar CRM centralizes all interactions and tracks them in real-time, giving you complete visibility. aissel.com/blog/streamlin…